2021 | Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B
| CLINICAL AND MOLECULAR HEPATOLOGY |
2021 | Association Between Curative Treatment after Transarterial Radioembolization and Better Survival Outcomes in Patients with Hepatocellular Carcinoma | CANCER INVESTIGATION |
2020 | Sarcopenia Is Independently Associated with the Degree of Liver Fibrosis in Patients with Type 2 Diabetes Mellitus
| GUT AND LIVER |
2020 | Entecavir and tenofovir on renal function in patients with hepatitis B virus-related hepatocellular carcinoma | JOURNAL OF VIRAL HEPATITIS |
2020 | Proposal of a New Risk Score for Patients Treated with Transarterial Chemoembolization due to Recurrent Hepatocellular Carcinoma after Curative Resection: A Multicenter Study
| GUT AND LIVER |
2020 | Establishment and Validation of a Risk Prediction Model in Patients With Hepatocellular Carcinoma Treated With Transarterial Radioembolization | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
2020 | A Tool to Measure the Impact of Inaction Toward Elimination of Hepatitis C: A Case Study in Korea
| PLOS ONE |
2020 | An observational study on long-term renal outcome in patients with chronic hepatitis B treated with tenofovir disoproxil fumarate | JOURNAL OF VIRAL HEPATITIS |
2019 | Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir
| CLINICAL AND MOLECULAR HEPATOLOGY |
2019 | Conditional Survival Estimates Improve Over Time for Patients with Hepatocellular Carcinoma: An Analysis for Nationwide Korea Cancer Registry Database
| CANCER RESEARCH AND TREATMENT |
2019 | Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection
| PLOS ONE |
2019 | Predictors of Discordance in the Assessment of Skeletal Muscle Mass between Computed Tomography and Bioimpedance Analysis
| JOURNAL OF CLINICAL MEDICINE |
2018 | Assessment of fibrotic burden among chronic hepatitis B virus-infected patients with normal transaminase level
| CLINICAL AND MOLECULAR HEPATOLOGY |
2018 | Long-term outcomes after noncurative endoscopic resection of early gastric cancer: the optimal time for additional endoscopic treatment. | GASTROINTESTINAL ENDOSCOPY |
2018 | Reproducibility of European Association for the Study of the Liver criteria and modified Response Evaluation Criteria in Solid Tumors in patients treated with sorafenib | LIVER INTERNATIONAL |
2018 | Feasibility of dynamic risk prediction for hepatocellular carcinoma development in patients with chronic hepatitis B | LIVER INTERNATIONAL |
2017 | Survival Estimates after Stopping Sorafenib in Patients with Hepatocellular Carcinoma: NEXT Score Development and Validation
| GUT AND LIVER |
2017 | Additive endoscopic resection may be sufficient for patients with a positive lateral margin after endoscopic resection of early gastric cancer | GASTROINTESTINAL ENDOSCOPY |
2017 | Gamma-glutamyl transpeptidase-to-platelet ratio is an independent predictor of hepatitis B virus-related liver cancer | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2017 | Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis | HEPATOLOGY INTERNATIONAL |